Reply: Fetal safety of dydrogesterone: clarifying the role of pharmacovigilance.

Chouchana L, Henry A, Bourdon M, Maignien C, Chapron C, Treluyer JM, Guibourdenche J, Santulli P

Open source

DOI
10.1093/hropen/hoaf031
Published
2025
Container
Human reproduction open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/hropen/hoaf031,
  title = {Reply: Fetal safety of dydrogesterone: clarifying the role of pharmacovigilance.},
  author = {Chouchana L and Henry A and Bourdon M and Maignien C and Chapron C and Treluyer JM and Guibourdenche J and Santulli P},
  year = {2025},
  journal = {Human reproduction open},
  doi = {10.1093/hropen/hoaf031},
  url = {https://doi.org/10.1093/hropen/hoaf031}
}

RIS

TY  - JOUR
TI  - Reply: Fetal safety of dydrogesterone: clarifying the role of pharmacovigilance.
AU  - Chouchana L
AU  - Henry A
AU  - Bourdon M
AU  - Maignien C
AU  - Chapron C
AU  - Treluyer JM
AU  - Guibourdenche J
AU  - Santulli P
PY  - 2025
JO  - Human reproduction open
DO  - 10.1093/hropen/hoaf031
UR  - https://doi.org/10.1093/hropen/hoaf031
ER  - 

APA

L, C., A, H., M, B., C, M., C, C., JM, T., J, G., & P, S. (2025). Reply: Fetal safety of dydrogesterone: clarifying the role of pharmacovigilance.. Human reproduction open. https://doi.org/10.1093/hropen/hoaf031

Source records